AstraZeneca Plc (NASDAQ:AZN) released high-level results from the MATTERHORN Phase 3 trial evaluating Imfinzi (durvalumab) as ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

Other symptoms of stomach cancer include unexplained weight loss, black stools containing blood (melaena), nausea and ...

The common phenomenon is often linked to eating and drinking habits but if it persists it could be a sign of something more ...

The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...

If you have difficulty swallowing, a lump in your stomach, or have lost a significant amount of weight, it's crucial that you ...

AstraZeneca (AZ) has shared positive results from a late-stage trial of its Imfinzi (durvalumab)-based perioperative regimen ...

The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...

Dad, 42, felt pain when he ate, which turned into back pain. He had Stage 3 pancreatic cancer, one of the deadliest cancers.

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

The NHS has shared the subtle signs of a rare but serious form of cancer. Many of these red flags could easily be ignored and ...